Zacks: Analysts Set $4.50 Price Target for Arotech Co. (ARTX)
Arotech Co. (NASDAQ:ARTX) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Brokers have set a 12 month consensus price objective of $4.50 for the company and are forecasting that the company will post $0.08 EPS for the current quarter, according to Zacks. Zacks has also given Arotech an industry rank of 105 out of 265 based on the ratings given to related companies.
Several equities research analysts recently issued reports on the company. Zacks Investment Research lowered Arotech from a “buy” rating to a “sell” rating in a research report on Tuesday, November 14th. B. Riley reissued a “buy” rating and set a $4.50 price target on shares of Arotech in a research report on Friday, November 10th.
Arotech (NASDAQ:ARTX) last posted its quarterly earnings results on Wednesday, November 8th. The aerospace company reported $0.06 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.04). The firm had revenue of $25.93 million for the quarter, compared to analyst estimates of $24.48 million. Arotech had a negative net margin of 2.87% and a positive return on equity of 3.27%. equities research analysts forecast that Arotech will post 0.14 earnings per share for the current fiscal year.
A number of institutional investors and hedge funds have recently modified their holdings of ARTX. GSA Capital Partners LLP grew its stake in Arotech by 105.1% during the 2nd quarter. GSA Capital Partners LLP now owns 166,100 shares of the aerospace company’s stock worth $590,000 after buying an additional 85,100 shares during the last quarter. Vanguard Group Inc. grew its stake in Arotech by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,038,240 shares of the aerospace company’s stock worth $3,686,000 after buying an additional 19,082 shares during the last quarter. Finally, Zacks Investment Management bought a new position in Arotech during the 2nd quarter worth $149,000. Hedge funds and other institutional investors own 20.89% of the company’s stock.
WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/05/zacks-analysts-set-4-50-price-target-for-arotech-co-artx.html.
Arotech Company Profile
Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Arotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech and related companies with MarketBeat.com's FREE daily email newsletter.